Announcements Trials
Browse Landscape

Phase

Phase 2 13Phase 3 3Phase 1/2 2Phase EARLY_PHASE1 1

Status

Active not recruiting 44Recruiting 19Completed 18Not yet recruiting 3Withdrawn 1Unknown 1Terminated 1Enrolling by invitation 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Carcinoma, Non-Small-Cell Lung 2Small Cell Lung Carcinoma 1Pancoast Syndrome 1

Interventions

Paclitaxel 24Oxaliplatin 24Capecitabine 24Gemcitabine 21Cisplatin 21Fluorouracil 20Drug Therapy 18Docetaxel 18Carboplatin 17pembrolizumab 15Leucovorin 15Irinotecan 15Radiotherapy 12tislelizumab 11Magnetic Resonance Spectroscopy 10Bevacizumab 10Specimen Handling 9Pemetrexed 9Radiation 8Injections 8Cetuximab 8toripalimab 7Surgical Procedures, Operative 7Radiotherapy, Intensity-Modulated 7Azacitidine 7venetoclax 6sintilimab 6Trastuzumab 6Topotecan 6Standard of Care 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 3 × Not yet recruiting × durvalumab × Clear all
NCT07554339 2026-04-28

KANDLELIT-015

Merck Sharp & Dohme LLC

Phase 3 Not yet recruiting
310 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT06719336 2024-12-05

Addition of Thoracic Consolidation Radiotherapy to the Maintenance Immunotherapy for ES-SCLC (STONE-001)

Peking University Cancer Hospital & Institute

Phase 3 Not yet recruiting
182 enrolled
Thoracic

Small Cell Lung Carcinoma

NCT04465968 2020-07-10

DEEP_OCEAN

National Cancer Center Hospital East

Phase 3 Not yet recruiting
84 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Pancoast Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon âš¡